Journal of Neuro-Oncology

Article	Citations
Complete resolution of peritumoral FLAIR hyperintensity is infrequent in surgically treated patients with intracranial meningiomas	78
Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence	66
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma	60
Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	57
Whole Body-MRI assessment of peripheral lesions in patients with NF2-related schwannomatosis on systemic bevacizumab	47
Comment on: “Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma”	45
Whole exome sequencing study of adamantinomatous craniopharyngioma reveals the mutational characteristics of recurrent cases	45
Thalamic involvement in glioblastoma is associated with lower risk of seizures: a retrospective cohort study	44
Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis	43
Variables associated with 90-day readmission following craniotomy for tumor in the pediatric population	42
Early outcomes of Gamma Knife stereotactic radiosurgery for symptomatic intracranial meningiomas in octogenarians: technique analysis and rationale	40
Two is better than one: longitudinal detection and volumetric evaluation of brain metastases after Stereotactic Radiosurgery with a deep learning pipeline	39
Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update	38
Letter: Exploring cell-free DNA as a biomarker for assessing tumor burden in metastatic spine disease	36
Immunotherapy approaches for the treatment of relapsed or progressive medulloblastoma	36
Different clinical and cytogenetic features of primary skull base meningiomas and non-skull base meningiomas	35
Predictors of brain metastases in patients with oligometastatic solid tumours treated with stereotactic body radiation therapy	34
Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study	34
Repeated responders to bevacizumab combination treatment in recurrent glioblastoma: a retrospective case study	33
Update of NK cell therapy in pediatric brain tumors	33
Prognostic factors among patients with brain metastases from cancer of unknown primary site	30
The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management	30
Differentiating radiation necrosis from tumor recurrence: a systematic review and diagnostic meta-analysis comparing imaging modalities	29
Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor	29
Repeat stereotactic radiosurgery for treatment of brain metastases locally recurrent following initial radiosurgery	28

Preoperative meningioma vascularity index is associated with significantly increased intraoperative blood loss and greater risk of subtotal resection	28
Pseudoprogression in Koos grade 4 vestibular schwannomas following stereotactic radiosurgery: temporal dynamics and radiological predictors	28
Maximal resection improves survival in MGMT methylated very elderly glioblastoma patients	27
Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival	27
Factors influencing timely diagnosis in neurolymphomatosis	26
Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases	26
Glioblastoma cell motility and invasion is regulated by membrane-associated heat shock protein Hsp70	26
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort stu	25
Multimodal pathomics and clinical features predict postresection permanent hydrocephalus in pediatric medulloblastoma	25
Distinct size and spatial distribution patterns of ALK-inhibitor-naïve versus ALK-inhibitor exposed ALK-positive NSCLC brain metastases	25
Oncological value of MRI in brain metastasis: exploring the potential of combining post-contrast T1 TSE (SPACE) and T1 GRE (MPRAGE) for stereotactic radiosurgery planning and surveillance	24
Early and late structural brain changes after radiation therapy: an MRI study in glioma patients	23
Optimizing the Stupp protocol for treatment of glioblastoma: eliminating age bias, enhancing treatment timing, use of stereotactically-guided sequential boost, and dexamethasone dosing	23
Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer	23
Journal of Neuro-Oncology, Meningioma issue	23
Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection	23
Patterns of response following gamma knife radiosurgery for tectal plate gliomas	23
The utility of long-term methylphenidate in preserving intellectual development in survivors of childhood brain tumour	22
Incidence, management, and outcome of incidental meningioma: what has happened in 10 years?	22
Management and treatment of brain tumors during pregnancy: an Italian survey	22
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44	21
Salvage dacomitinib plus intraventricular pemetrexed for leptomeningeal metastasis after failure of third‑generation EGFR‑TKIs in EGFR‑mutant NSCLC: an ambispective cohort study	21
The impact of distance in treating glioblastoma: a retrospective single-center study	21
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors	21
Brain metastases from ovarian cancer: neuroradiological profile and survival overview of neurosurgical cases	21
The concept, intention, and evaluation of the term treatment-refractory meningioma	21
Correction to: Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data	20
The role of spine stereotactic radiosurgery for patients with breast cancer metastases	20
Correction to: Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses	20
Correction to: A prospective study of minimally invasive keyhole craniotomy and stereotactic brachytherapy for new brain oligometastases	20
The evolving role of reirradiation in the management of recurrent brain tumors	20
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme	20
Candidate MRI biomarkers for CD79B status in primary CNS lymphoma: an exploratory radiogenomic analysis of the UCSF-PCNSL cohort	20
First-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound	20
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience	19
Predicting post-surgical functional status in high-grade glioma with resting state fMRI and machine learning	19
Implications and interchangeability of meningioma biomarkers for clinical trials and clinical practice	19
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024	18
Suberanilohydroxamic acid (SAHA), a HDAC inhibitor, suppresses the effect of Treg cells by targeting the c-Myc/CCL1 pathway in glioma stem cells and improves PD-L1 blockade therapy	18
Neuroradiological features of patients with bilateral macronodular adrenocortical disease and meningiomas associated or not with genetic variants of ARMC5– a case series	18
Integration of molecular pathology with histopathology to accurately evaluate the biological behaviour of WHO grade 2 meningiomas and patient prognosis	18
Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence	18
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients	18
Extent of resection and survival in IDH-wildtype glioblastoma: interaction with MGMT status and chemoradiation	18
Raman and autofluorescence spectroscopy for in situ identification of neoplastic tissue during surgical treatment of brain tumors	18
Radiotherapeutic advances in the management of glioblastoma	17
Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis	17
Genome-wide association study on meningioma risk in Japan: a multicenter prospective study	17
China National Glioma Registry (CNGR): protocol for a prospective observational registry study	17
Differences in regional developmental origins of glioblastomas revealed by integrated molecular profiling	17

Correction to: Acute side effects of proton and photon radiotherapy for medulloblastoma: a retrospective national multicenter study	17
IDH1 mutation is associated with improved resection rates, progression-free survival and overall survival in patients with anaplastic astrocytomas	17
Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma	17
ANG peptide-modified exosomes loaded with oleanolic acid target GPX4 for enhanced breast cancer brain metastasis therapy	17
Real-world cost- effectiveness analysis: Tumor Treating Fields for newly diagnosed glioblastoma in China	17
Comment on “The 5-factor modified frailty index as a prognostic factor for stereotactic radiosurgery in meningioma management”	17
Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control	17
The Journal of Neuro-Oncology: the last and next 40 years	17
Combined stereotactic radiotherapy and immunotherapy improves survival in driver-gene-negative NSCLC patients with brain oligo-metastases: a multicenter real-world study	17
Risk calculator for long-term survival prediction of spinal chordoma versus chondrosarcoma: a nationwide analysis	17
Genetic predictors of neurocognitive outcomes in survivors of pediatric brain tumors	17
Intratumoral tocilizumab in children with cystic craniopharyngiomas: targeted therapy	17
Clinical outcomes of three-fraction versus five-fraction stereotactic radiosurgery for resected brain metastases	16
Repurposing mebendazole against triple-negative breast cancer CNS metastasis	16
Comparative efficacy and safety of sodium fluorescein-guided surgery versus standard white light for resection of brain metastases: a systematic review and meta-analysis	16
Cost-effectiveness analysis of upfront HA-WBRT vs. SRS for treatment of brain metastases due to SCLC	16
Socioeconomic status and outcomes following spine stereotactic body radiation therapy	16
Beyond tumor control: symptom trajectories and hearing outcomes after contemporary Gamma Knife radiosurgery for vestibular schwannoma	16
Low tumour burden is associated with observation after surgery in patients with grade 2 astrocytoma and oligodendroglioma: results from the prospective multicentre LoG-Glio registry	16
Anatomical and surgical characteristics correlate with pachymeningeal failure in patients with brain metastases after neurosurgical resection and adjuvant stereotactic radiosurgery	16
Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update	16
Pre-treatment systemic inflammation response index and systemic immune inflammation in patients with primary central nerve system lymphoma as a useful prognostic indicator	16
Can we make it up? - second-look surgery due to post-operative residual tumour in patients diagnosed with diffuse glioma	16
The state of art of awake craniotomy in Latin American countries: a scoping review	16
Junctional adhesion molecular 3 (JAM3) is a novel tumor suppressor and improves the prognosis in breast cancer brain metastases via the TGF-β/Smad signal pathway	16
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT	16
Structural organization of neurosurgical care and its influence on long-term outcomes in glioma: evidence from a large single-center cohort in China	16
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients	16
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches	16
Preoperative assessment of eloquence in neurosurgery: a systematic review	15
Ciprofol reduces postoperative glioma recurrence by promoting MAPK11-PML phosphorylation: insights from transcriptomic and proteomic analysis	15
Stereotactic radiosurgery for patients with spinal metastases from prostate cancer	15
Elevating the findings by substituting in “ISarcoPRM”	15
The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study	15
Anatomical changes in resection cavity during brain radiotherapy	15
Clinical predictors of pseudoprogression in glioblastoma: a retrospective cohort analysis	15
Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis	15
Letter to the editor: surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study	15
Postoperative stereotactic radiosurgery for intracranial solitary fibrous tumors: systematic review and pooled quantitative analysis	15
Tissue biopsy before resection in glioblastoma: is there an opportunity to improve outcomes with liquid biopsies and pre-operative stereotactic radiosurgery?	15
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity	15
Long-term outcomes in IDH-wildtype (IDH-wt) gliomas with historical WHO grade 2 and 3 histology	15
Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR)	15
Outcomes of radiation-induced meningiomas treated with stereotactic radiosurgery	15
Cystic glioblastoma IDH-wildtype: genetic alterations and outcomes	15
Glioblastoma survival in rural America: a 10-year experience from a quaternary care center	14
ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449	14
Targeting ataxia-telangiectasia mutated and cystine/glutamate antiporter enhances radiotherapy efficacy and tumor suppression in glioblastoma	14
Impact of proton versus photon radiotherapy on overall survival in the management of spinal chordoma and mortality risk prediction: a nationwide analysis	14
Standardizing connectome-based brain tumor surgery through a network-based surgical nomenclature	14
Histopathological correlation of brain tumor recurrence vs. radiation effect post-radiosurgery as detected by MRI contrast clearance analysis: a validation study	14
NUDT21 alters glioma migration through differential alternative polyadenylation of LAMC1	14
Study of prediction model for high-grade meningioma using fractal geometry combined with radiological features	14
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104	14
Prognostic significance of H3.K27me3 loss in CNS WHO grade 2 meningiomas: a multicentre clinicopathological study	14
Evaluating the role of gross total resection in primary spinal cord glioblastoma: evidence from a multicenter cohort and meta-analysis	14
The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrence	14
Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion	14
The 4S of spinal astrocytoma: specific location, syrinx, spasticity and score on Modified Mccormick Scale (MMS) predict long term outcomes in patients undergoing surgical resection of intramedullary s	14
Intraoperative radiotherapy after resection of newly diagnosed brain metastases in adult patients - results of a prospective phase II trial (INTRAMET)	14
The role of MRI patterns in predicting neurologic deficits in spinal ependymomas	14
Brain metastases from colorectal cancer – a retrospective dual center study	13
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis	13
Targeting COL5A1 enhances anoikis thus attenuating malignancy of glioblastoma via inhibiting the Wnt/β-catenin signaling pathway	13
Epilepsy characteristics and outcomes in patients with pleomorphic xanthoastrocytomas	13
Hypofractionated vs. conventional fractionated radiotherapy in the temozolomide era for elderly patients with glioblastoma: a systematic review and meta-analysis by the Korean Society for Neuro-Oncolo	13
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery	13
Superficial meningioma with bone involvement: surgical strategies and clinical outcomes	13
CRYM suppresses glioblastoma progression by inhibiting the TGFβ1/Smad-EMT signaling pathway	13
High-dose furmonertinib combined with intraventricular chemotherapy as salvage therapy for leptomeningeal metastasis from EGFR exon 20 insertion-mutated lung cancer	13
Factors associated with cognitive impairment in long-term IDH-mutant glioma survivors	13
Immune checkpoint inhibitors for glioblastoma: emerging science, clinical advances, and future directions	13
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomide	13
Patient-derived glioma organoids real time identification of IDH mutation, 1p/19q-codeletion and CDKN2A/B homozygous deletion with differential ion mobility spectrometry	13
Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial	13
Therapeutic Hybrid Intelligence with Neural and Knowledge-based Expert Reasoning for SRS (THINKERS): an AI model for GBM	13
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws	13
The CCL2-CCR4 axis promotes Regulatory T cell trafficking to canine glioma tissues	13
Survival of nervous system tumors in a Colombian population cancer registry	13
Exploring the prognostic value of BRMS1 + microglia based on single-cell anoikis regulator patterns in the immunologic microenvironment of GBM	13

Correction to: Intrathecal chemotherapy for leptomeningeal disease in high-grade gliomas: a systematic review	13
Rethinking white matter–tumor interaction: a tractography based analysis of associations between fractional anisotropy and morphometry in the IFOF and arcuate fasciculus	13
NOTCH3 drives fatty acid oxidation and ferroptosis resistance in aggressive meningiomas	12
Correction to: The characteristics of brain structural remodeling in patients with unilateral vestibular schwannoma	12
The relationship between asthma and glioma: a case-control study in a universal access healthcare system	12
Single-fraction Gamma Knife radiosurgery for pineal region meningiomas: a retrospective single-center cohort of 44 patients	12
Prediction of double expression status of primary CNS lymphoma using multiparametric MRI radiomics combined with habitat radiomics: a double-center study	12
Peripheral hematological landscapes as biomarkers for detecting postoperative progression in glioblastoma multiforme: a multivariable risk scoring approach	12
cGAS-STING agonists in preclinical glioblastoma animal models: a systematic review of tumor microenvironment modulation and survival outcomes	12
Surgeon experience in glioblastoma surgery of the elderly—a multicenter, retrospective cohort study	12
Radiation-sparing management of WNT medulloblastoma of early childhood with high dose chemotherapy: In response to Gupta et al	12
Identification of NEK6 as a potential biomarker for prognosis in glioma and its functional implications	12
Large vestibular schwannoma treated using a cranial nerve sparing approach with planned subtotal microsurgical resection and stereotactic radiosurgery: meta-analysis and International Stereotactic Rad	12
Efficacy and safety of immune checkpoint inhibitors plus anlotinib in small cell lung cancer with brain metastases: a retrospective, multicentre study	12
Advanced imaging reveals enhanced malignancy in glioblastomas involving the subventricular zone: evidence of increased infiltrative growth and perfusion	12
Neuropsychological impairment in primary malignant brain tumor patients with awake craniotomy: a hospital-based registration study	12
Advanced imaging characterization of post-chemoradiation glioblastoma stratified by diffusion MRI phenotypes known to predict favorable anti-VEGF response	12
Computerized assessment of neuropsychological functioning in pediatric brain tumor patients	12
Preoperative frailty measured by risk analysis index predicts complications and poor discharge outcomes after Brain Tumor Resection in a large multi-center analysis	12
Resection of craniopharyngiomas: comparison between gross total resection and subtotal resection with adjuvant radiation	12
Outcomes of early versus late radiotherapy in grade 2 meningiomas: a National retrospective analysis from the TROD neuro-oncology group	12
Diagnostic utility of liquid biopsies in pediatric brain tumors: a systematic review	12
Long-term outcomes of modern radiation therapy for pituitary adenoma – different techniques: single institute experience	12
Repeated stereotactic radiosurgery for high grade meningioma	12
Racial disparities in the management and outcomes of primary osseous neoplasms of the spine: a SEER analysis	12
Long-term outcomes of central neurocytoma – an institutional experience	11
Awake craniotomy for brain tumor resection in the elderly: an institutional experience	11
Comparative safety and survival outcomes of immune checkpoint inhibitors in brain metastases from lung cancer: a propensity-matched cohort study	11
Virus-like particle vaccine targeting meningeal lymphatic vessels via intradural delivery activates anti-glioma immunity	11
The cognitive functions and seizure outcomes of patients with low-grade epilepsy-associated neuroepithelial tumors	11
The magnitude of surgical site infection and its associated factors among pediatric central nervous system (CNS) tumor patients at tertiary referral hospitals in Ethiopia: a multi-center study	11
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study	11
Demographic variations and time to initiation of adjunct treatment following surgical resection of anaplastic astrocytoma in the United States: a National Cancer Database analysis	11
Construction and application of an ERAS-based nursing pathway for postoperative pain management in brain tumor patients	11
Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment	11
The association of hospital volume status with treatment and survival outcomes of intracranial meningioma patients: a multivariable analysis of the National Cancer Database	11
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center	11
Clinicopathological factors associated with brain metastases development among breast cancer patients receiving neoadjuvant chemotherapy	11
Pre-operative blood-based inflammatory indices and long-term facial nerve outcomes following vestibular schwannoma resection	11
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications	11
Short-term sensorimotor training incorporating cognitive tasks for pediatric survivors of posterior fossa tumors: a pilot study	11
Frequency of and risk factors associated with local recurrence after spinal stereotactic body radiation therapy without surgery	11
Particle beam radiotherapy in the treatment of WHO grade 2 and 3 meningiomas: an early experience from Shanghai Proton and Heavy Ion Center	11
Surgical characteristics and survival outcomes of pediatric pineal region tumors: a cohort study in Vietnam	11
The patients’ experience of neuroimaging of primary brain tumors: a cross-sectional survey study	11
Impact of seizures and antiseizure medication on survival in patients with glioma	11
Multimodal treatment of glioblastoma with multiple lesions - a multi-center retrospective analysis	11
Stereotactic body radiation therapy for spinal metastases from gastrointestinal primary cancers	11
Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma	11
Disrupting Akt-Wnt/β-catenin signaling suppresses glioblastoma stem cell growth and tumor progression in immunocompetent mice	11
Dual AI models for gamma knife radiosurgery in craniopharyngioma: prescription dose modeling and outcome risk prediction	11
Comment on “Amino-acid PET as a prognostic tool after post-stupp protocol temozolomide therapy in high-grade glioma patients”	11
High-grade glioma imaging volumes and survival: a single-institution analysis of 101 patients after resection using intraoperative MRI	11
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol	11
Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?	11
Correction to: Prognostic relevance and cytokine correlates of peripheral immune subpopulations in newly diagnosed glioblastoma	11
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study	11
Postoperative absence of residual intracranial tumor volume is associated with improved survival and intracranial disease control in non-small cell lung cancer brain metastases	11
The promise and potential of porphyrin metabolite activation using sonodynamic therapy for the treatment of glioblastoma	11
Regression of sporadic CNS hemangioblastomas with belzutifan	11
An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma	11
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience	10
Comparative analysis of hypofractionated short-course versus standard radiation therapy in elderly patients with glioblastoma: analysis of nationwide database	10
Optimizing reirradiation for relapsed medulloblastoma: identifying the ideal patient and tumor profiles	10
Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis	10
Overexpression of LSR suppresses glioma proliferation and invasion via regulating FOXO3a	10
Magnetic resonance imaging signal characteristics associated with prognosis of skull base chordoma after gamma knife radiosurgery	10
National and institutional capacity building with international collaboration to advance pediatric neuro-oncology care in Ethiopia: a baseline need assessment survey	10
Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study	10
Prognostic relevance of resection at first recurrence in isocitrate dehydrogenase mutant lower-grade glioma: results from a retrospective, single-center, volumetric analysis	10
Perilesional resection technique of glioblastoma: intraoperative ultrasound and histological findings of the resection borders in a single center experience	10
From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma	10
Physical function, body mass index, and fitness outcomes in children, adolescents, and emerging adults with craniopharyngioma from proton therapy through five years of follow-up	10
The METACER national cohort study of brain metastases in gastrointestinal cancers prospectively establishes prognostic factors	10
CT perfusion–focused preoperative assessment of the blood-supplying state among imaging modalities in skull base chordoma: a retrospective single-center cohort	10
Financial toxicity in patients with glioblastoma	10
Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases	10
Transcriptome sequencing analysis revealed the molecular mechanism of BNCT inhibiting the growth of U87 subcutaneous tumor	10
Correction to: Efficacy and safety of BRAF-MEK dual inhibition in BRAF-V600E mutated papillary craniopharyngioma: a systematic review	10
Pharmaceutical equivalent 5-aminolevulinic acid fluorescence guided resection of central nervous system tumors: feasibility, safeness and cost-benefit considerations	10
Expression of ABCB1, ABCC1 and 3 and ABCG2 in glioblastoma and their relevance in relation to clinical survival surrogates	10
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma	10
Efficacy of chemoradiotherapy in pediatric H3K27M-mutant diffuse intrinsic pontine glioma: a study based on single-center and SEER data	10
Additive risk of surgical site infection from more than one risk factor following craniotomy for tumor	10
Correction to: Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in differentiating between brain tumor progression versus pseudoprogression and radionecrosis	10
Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery	10
Algorithm-based assessment of T-cell dysfunction and exclusion to forecast ICB sensitivity in pediatric brain ependymoma	10
The dynamic nature of frailty in metastatic spine disease patients	10
Neurocognitive and radiological follow-up of children under 5 years of age treated for medulloblastoma according to the HIT-SKK protocol	10
Factors affecting postoperative seizure risk and perioperative outcomes in pediatric brain tumor resections	10
Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience	10
Likelihood-of-harm/help of microsurgery compared to radiosurgery in large vestibular schwannoma	10
Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis	10
Interstitial photodynamic therapy for newly diagnosed glioblastoma	10
APTw CEST MRI in therapy-naive IDH-wildtype glioblastoma: insights into tumor heterogeneity and molecular subtypes	10